Pilot Test of a Community-based Buprenorphine Treatment Intervention
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01761110|
Recruitment Status : Completed
First Posted : January 4, 2013
Last Update Posted : April 23, 2018
|Condition or disease||Intervention/treatment||Phase|
|Opioid Dependence Injection Drug Use||Behavioral: Community-based buprenorphine treatment (CBBT) intervention||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||77 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Development of a Community-based Buprenorphine Treatment Intervention|
|Study Start Date :||December 2012|
|Actual Primary Completion Date :||February 2014|
|Actual Study Completion Date :||February 2014|
No Intervention: Pre-intervention
Participants will be enrolled prior to the implementation of the community-based buprenorphine treatment (CBBT) intervention.
Participants will be enrolled after implementing the community-based buprenorphine treatment (CBBT) intervention
Behavioral: Community-based buprenorphine treatment (CBBT) intervention
Community-based buprenorphine treatment (CBBT) intervention consists of three components which are delivered to staff of syringe exchange programs, including: 1) providing buprenorphine education, 2) facilitating access to buprenorphine treatment, and 3) providing support to individuals who initiate buprenorphine treatment.
- initiation of buprenorphine treatment [ Time Frame: 60 days ]Medical record information will be extracted to determine initiation of buprenorphine treatment, which will be defined as a visit with a medical provider in which buprenorphine is prescribed.
- opioid use [ Time Frame: 60 days ]Opioid use will be determined via self-report using the Addiction Severity Index and via urine specimens (e.g., urine toxicology testing).
- HIV risk behaviors [ Time Frame: 60 days ]Drug- and sex-related HIV risk behaviors will be assessed using a standardized risk assessment tool used in NIDA's Clinical Trials Network.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01761110
|United States, New York|
|Washington Heights Corner Project|
|New York, New York, United States, 10033|
|Principal Investigator:||Chinazo Cunningham, MD, MS||Albert Einstein College of Medicine|